Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non–small cell lung cancer patients

Por Choughule, A, Noronha, V, Joshi, A, Desai, S, Jambhekar, N, Utture, S, Thavamanni, A, Prabhash, K, Dutt, A
Publicado no Indian J Cancer (2013)

Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Por Choughule, A, Sharma, R, Trivedi, V, Thavamani, A, Noronha, V, Joshi, A, Desai, S, Chandrani, P, Sundaram, P, Utture, S, Jambhekar, N, Gupta, S, Aich, J, Prabhash, K, Dutt, A
Publicado no Br J Cancer (2014)

Drug-sensitive FGFR3 mutations in lung adenocarcinoma

Por Chandrani, P., Prabhash, K., Prasad, R., Sethunath, V., Ranjan, M., Iyer, P., Aich, J., Dhamne, H., Iyer, D. N., Upadhyay, P., Mohanty, B., Chandna, P., Kumar, R., Joshi, A., Noronha, V., Patil, V., Ramaswamy, A., Karpe, A., Thorat, R., Chaudhari, P., Ingle, A., Choughule, A., Dutt, A.
Publicado no Ann Oncol (2017)